Genotype and Disease Burden of RSV in Older Vietnamese Adults (RSV: Respiratory Syncytial Virus )
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60+
SponsorTam Anh Research Institute
About this trial
This observational, prospective, multicenter study aims to estimate the proportion of RSV infection in adults aged 60 years and older hospitalized due to acute respiratory infections or exacerbation of cardiopulmonary disease.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Individuals ≥ 60 years old at the time of screening (calculated from the date of birth to the date of screening)
New onset or increase from baseline of: nasal congestion, rhinorrhea, sore throat, hoarseness, cough, sputum production, dyspnea, wheezing, hypoxemia, or
Admitting diagnosis suggestive of ARI (e.g., pneumonia, upper respiratory infection, bronchitis, influenza, cough, viral respiratory illness, respiratory distress, or respiratory failure), or
Admitting diagnosis was the exacerbation of an underlying cardiac or pulmonary disease involving acute respiratory symptoms within the previous 2 weeks (e.g., congestive heart failure [CHF], chronic obstructive pulmonary disease [COPD], or asthma exacerbation).
Disqualifiers
Symptom onset > 6 days prior to screening date
Acute symptoms confirmed to be unrelated to infection or as assessed by the investigator
Admission to any hospital within the 30 days preceding the screening date
Previously enrolled in the study in the last 45 days
Trial population
Hospitalized adults aged ≥60 years with acute respiratory infections at Tam Anh TP. Ho Chi Minh General Hospital and Tam Anh General Hospital
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
The proportion of RSV infection in adults aged 60 years and older hospitalized due to acute respiratory infections or exacerbation of cardiopulmonary disease.
The proportion of participants with laboratory-confirmed RSV infection (including RSV A and RSV B) among adults aged ≥60 years hospitalized for acute respiratory infection or cardiopulmonary disease exacerbation. Diagnosis will be based on qualitative PCR results from nasopharyngeal or sputum samples.
Time frame
Within 24 hours after hospital admissionSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov